Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 31017622.
- Also identified by DOI 10.1001/jamadermatol.2019.0279.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Is the use of ivermectin in patients infested with scabies associated with improved clinical and safety outcomes compared with permethrin? Both ivermectin and permethrin treatment were associated with high clearance rates. There is low-certainty evidence that ivermectin was associated with slightly lower rates of complete clearance after 1 week compared with permethrin, 5%, cream (relative risk [RR], 0.65; 95% CI, 0.54-0.78). After 2 weeks, there was no difference in efficacy (RR, 0.91; 95% CI, 0.76-1.08; low-certainty evidence), or in the number of participants with adverse events (week 4: RR, 1.30; 95% CI, 0.35-4.83; low-certainty evidence).
Medical subject headings
- Ivermectin
- Permethrin
- Scabies